DMS S.A. INH. EO 11845
Diagnostic Medical Systems S.A. engages in the design, development, manufacture, and sale of medical imaging systems in France. It offers ADAM, in-house software suite; R and F solutions; bone densitometry; chest and bone room; mobile; c-arm; retrofit kit; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France.
DMS S.A. INH. EO 11845 (DMS1) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, DMS S.A. INH. EO 11845 (DMS1) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
DMS S.A. INH. EO 11845 - Net Assets Trend (None–None)
This chart illustrates how DMS S.A. INH. EO 11845's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for DMS S.A. INH. EO 11845 (None–None)
The table below shows the annual net assets of DMS S.A. INH. EO 11845 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to DMS S.A. INH. EO 11845's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
DMS S.A. INH. EO 11845 Competitors by Market Cap
The table below lists competitors of DMS S.A. INH. EO 11845 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Telcon Inc
KQ:200230
|
$12.33 Million |
|
Hookipa Pharma Inc
NASDAQ:HOOK
|
$12.33 Million |
|
SAGA PURE ASA NK 1
F:SAT
|
$12.33 Million |
|
Tron Inc.
NASDAQ:TRON
|
$12.33 Million |
|
Bintai Kinden Corporation Bhd
KLSE:6998
|
$12.31 Million |
|
Eastern Platinum Limited
PINK:ELRFF
|
$12.31 Million |
|
Mlk Foods Public Company Ltd
WAR:MLK
|
$12.31 Million |
|
Qingdao Hengshun Zhongsheng
SHE:300208
|
$12.31 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DMS S.A. INH. EO 11845's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares DMS S.A. INH. EO 11845's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently DMS S.A. INH. EO 11845 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares DMS S.A. INH. EO 11845's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DMS S.A. INH. EO 11845 (DMS1) | €- | N/A | N/A | $12.33 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |